WOONSOCKET, R.I., Aug. 5, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) is prioritizing the health and safety of its customers, patients, members and colleagues as Hurricane Debby lands in Florida and travels through Georgia and the Carolinas this week. The company is committed to providing communities with access to the products and services they need amid the storm. It has implemented measures across its business to ensure continuity of care:
CVS Pharmacy stores comply with all local evacuation orders. If there are mandatory closures, impacted stores will reopen as soon as it is safe to do so. If a store is closed for more than one day, the pharmacy's phone lines will be rerouted to a nearby open CVS Pharmacy to help patients access their prescriptions. Patients with a scheduled vaccination will be notified of any changes to their appointment by email or text message.
CVS Health also recommends the following tips to ensure prescription needs are met for those potentially impacted by Hurricane Debby:
CVS Health remains dedicated to supporting its local communities and is in contact with disaster relief organizations to help communities respond to and recover from the storm.
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health — whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system — and their personal health care — by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
Media contact
Kara Page
401-302-9353
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$44.36 |
Daily Change: | 0.58 1.32 |
Daily Volume: | 18,754,397 |
Market Cap: | US$55.890B |
November 19, 2024 November 18, 2024 November 06, 2024 November 06, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB